Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus VaccineBusiness Wire • 08/20/20
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing AntibodiesBusiness Wire • 07/22/20